Prevalence and associations of erectile dysfunction in a sample of Italian males with type 2 diabetes

Diabetes Research and Clinical Practice
Giuseppe DerosaPamela Maffioli

Abstract

The aim of this study was to evaluate the prevalence of erectile dysfunction (ED) in a sample of type 2 diabetic patients. As secondary endpoint, we evaluated the levels of some adipocytokines in patients with and without ED. We enrolled 220 males affected by type 2 diabetes mellitus. We administered the IIEF (International Index of Erectile Function), SAS (self-rating anxiety scale) and SDS (self-rating depression scale) questionnaires. We evaluated body mass index, glycemic control, fasting plasma insulin (FPI), homeostasis model assessment of insulin resistance index (HOMA-IR), lipid profile, sexual hormones, adiponectin (ADN), resistin, retinol binding protein-4 (RBP-4), visfatin, vaspin. 52.9% of patients were affected by ED. Patients with a HbA1c <7% (53 mmol/mol) in all measurements in the two previous years had a lower incidence of ED, while the prevalence of ED increased with the increasing of times HbA1c was >7% (53 mmol/mol). Patients with ED had higher levels of triglycerides, and higher levels of FPI, 9.9 μU/ml vs 8.2 μU/ml (p<0.05). Resistin levels were higher in patients with ED compared to those without ED (p<0.05) and free testosterone was lower in patients affected by ED. Almost half of type 2 diabetic patient...Continue Reading

Associated Clinical Trials

References

Dec 14, 1989·The New England Journal of Medicine·R J KraneI Saenz de Tejada
Nov 1, 1971·Psychosomatics·W W Zung
Jun 1, 1984·Diabetologia·D K McCullochB F Clarke
Nov 1, 1982·Clinics in Endocrinology and Metabolism·V Michal
Jul 7, 1993·JAMA : the Journal of the American Medical Association
Sep 19, 2000·The Journal of Urology·M BurchardtR Shabsigh
Jun 14, 2001·The Urologic Clinics of North America·R W Lewis
Jan 1, 1965·Archives of General Psychiatry·W W ZUNG
May 20, 2005·International Journal of Impotence Research·K Esposito, D Giugliano
May 15, 2007·Fertility and Sterility·J C Trussell, Richard S Legro
May 26, 2009·Heart and Vessels·Giuseppe DerosaArrigo F G Cicero
Mar 11, 2010·The Journal of Sexual Medicine·Antonio Hernández-MijaresVíctor Manuel Víctor
Apr 3, 2010·Microvascular Research·Giuseppe DerosaArrigo F G Cicero
Apr 15, 2010·The Journal of Sexual Medicine·Ronald W LewisTaylor Segraves
May 11, 2012·Endocrine Journal·Giuseppe DerosaPamela Maffioli
Mar 8, 2013·Inflammation·Giuseppe DerosaPamela Maffioli

❮ Previous
Next ❯

Citations

Sep 21, 2017·International Journal of Environmental Research and Public Health·Ewelina BąkAgnieszka Drosdzol-Cop
Oct 20, 2018·American Journal of Men's Health·Moustafa A ElsaiedIbrahim A Abdel-Hamid
Nov 25, 2017·Diabetic Medicine : a Journal of the British Diabetic Association·M AlgeffariN Oliver
Aug 4, 2018·Current Diabetes Reviews·Mortaza F Hassanabad, Mohammad Fatehi
Feb 1, 2020·Reviews in Endocrine & Metabolic Disorders·Damiano PizzolNicola Veronese
May 2, 2021·Diabetes & Metabolic Syndrome·Yehia M GhanemAmr Y El Feky

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Auditory Perception

Auditory perception is the ability to receive and interpret information attained by the ears. Here is the latest research on factors and underlying mechanisms that influence auditory perception.